Persistent hyperglycemia in DKD patients triggers inflammatory pathways, including nuclear factor-κ B (NF-κ B), via mechanisms involving oxidative stress, the buildup of advanced glycation end products (AGEs), and activation of the renin-angiotensin system (RAS). The gene discussed is REN; the disease is Hyperglycemia.